CoMind Welcomes Frank Fischer as Chairman of Board of Directors
We are thrilled to announce the appointment of Frank Fischer as Chairman of the board of directors. Frank is an industry veteran leading innovative medical device companies for over 40 years, and will help CoMind to achieve its mission of redefining the way the brain is measured and treated to optimise patient outcomes across the care continuum.
Read more
CoMind Welcomes Dr. Michael Tarnoff to the Board of Directors
CoMind is proud to announce the appointment of Dr. Michael Tarnoff, MD, FACS, to the Board of Directors. Dr. Tarnoff brings a wealth of experience in healthcare management and surgical expertise to CoMind, bolstering the company’s leadership as it continues to redefine brain measurement and treatment for optimal patient outcomes.
Read more
CoMind Attends SPIE Photonics West 2025
CoMind is excited to announce that after several years of advancing our unique optical neuromonitoring technology, we will be presenting our work for the first time at SPIE Photonics West in San Francisco with four talks. Please click the link at the top of this article to find out more!
Read more
11 medical device startups to watch, according to investors
CoMind is developing non-invasive neural sensors aiming to enable better assessment and treatment for complex neurological conditions. Often neuroscience and neurosurgical conditions are limited in how they can measure important parameters for clinical management and CoMind addresses this problem.
Read more
30 Under 30 – Europe – Technology (2022)
James Dacombe, a Thiel Fellow, dropped out of high school at age 16 to work as a software engineer at a startup and then left that to build CoMind at 17. The London-based, neurotechnology startup, which has raised $15 million, aims to develop a neurosensing technology that would catalyze a new wave of neuroscience and neurology applications within medical devices.
Read more